A Rare Case of Pembrolizumab Associated Encephalopathy

We present a unique case of a 55-year-old man with confusion thought to be due to pembrolizumab which he was receiving for renal cell carcinoma. His workup for other possible etiologies for encephalopathy was negative. He was treated with high dose intravenous methylprednisolone followed by predniso...

Descripción completa

Detalles Bibliográficos
Autores principales: Basnet, Sijan, Singh, Rajanbir, Tharu, Biswaraj, Pawar, Tushar, Basnet, Garima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Greater Baltimore Medical Center 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529659/
https://www.ncbi.nlm.nih.gov/pubmed/36262501
http://dx.doi.org/10.55729/2000-9666.1091
_version_ 1784801546969546752
author Basnet, Sijan
Singh, Rajanbir
Tharu, Biswaraj
Pawar, Tushar
Basnet, Garima
author_facet Basnet, Sijan
Singh, Rajanbir
Tharu, Biswaraj
Pawar, Tushar
Basnet, Garima
author_sort Basnet, Sijan
collection PubMed
description We present a unique case of a 55-year-old man with confusion thought to be due to pembrolizumab which he was receiving for renal cell carcinoma. His workup for other possible etiologies for encephalopathy was negative. He was treated with high dose intravenous methylprednisolone followed by prednisone taper and intravenous immunoglobulin with gradual improvement in his mentation.
format Online
Article
Text
id pubmed-9529659
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Greater Baltimore Medical Center
record_format MEDLINE/PubMed
spelling pubmed-95296592022-10-18 A Rare Case of Pembrolizumab Associated Encephalopathy Basnet, Sijan Singh, Rajanbir Tharu, Biswaraj Pawar, Tushar Basnet, Garima J Community Hosp Intern Med Perspect Case Report We present a unique case of a 55-year-old man with confusion thought to be due to pembrolizumab which he was receiving for renal cell carcinoma. His workup for other possible etiologies for encephalopathy was negative. He was treated with high dose intravenous methylprednisolone followed by prednisone taper and intravenous immunoglobulin with gradual improvement in his mentation. Greater Baltimore Medical Center 2022-09-09 /pmc/articles/PMC9529659/ /pubmed/36262501 http://dx.doi.org/10.55729/2000-9666.1091 Text en © 2022 Greater Baltimore Medical Center https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ).
spellingShingle Case Report
Basnet, Sijan
Singh, Rajanbir
Tharu, Biswaraj
Pawar, Tushar
Basnet, Garima
A Rare Case of Pembrolizumab Associated Encephalopathy
title A Rare Case of Pembrolizumab Associated Encephalopathy
title_full A Rare Case of Pembrolizumab Associated Encephalopathy
title_fullStr A Rare Case of Pembrolizumab Associated Encephalopathy
title_full_unstemmed A Rare Case of Pembrolizumab Associated Encephalopathy
title_short A Rare Case of Pembrolizumab Associated Encephalopathy
title_sort rare case of pembrolizumab associated encephalopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529659/
https://www.ncbi.nlm.nih.gov/pubmed/36262501
http://dx.doi.org/10.55729/2000-9666.1091
work_keys_str_mv AT basnetsijan ararecaseofpembrolizumabassociatedencephalopathy
AT singhrajanbir ararecaseofpembrolizumabassociatedencephalopathy
AT tharubiswaraj ararecaseofpembrolizumabassociatedencephalopathy
AT pawartushar ararecaseofpembrolizumabassociatedencephalopathy
AT basnetgarima ararecaseofpembrolizumabassociatedencephalopathy
AT basnetsijan rarecaseofpembrolizumabassociatedencephalopathy
AT singhrajanbir rarecaseofpembrolizumabassociatedencephalopathy
AT tharubiswaraj rarecaseofpembrolizumabassociatedencephalopathy
AT pawartushar rarecaseofpembrolizumabassociatedencephalopathy
AT basnetgarima rarecaseofpembrolizumabassociatedencephalopathy

Ejemplares similares